search-iconcartsearch-iconcart
Home
>
Reports
>
Pharmaceuticals
>
Hormone-refractory-prostate-cancer-market

Hormone Refractory Prostate Cancer (HRPCA) Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 24
SKU : PH3383
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350$3480
Multiple User
$4850$3880
Enterprise User
$7850$6280
Proceed to Buy
Request new version
FAQ’s

Related Reports
pharmaceuticals

Foveal Atrophy Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350

pharmaceuticals

Chronic Disease Management Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350

pharmaceuticals

Alpha-1 Antitrypsin Deficiency Therapy Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 November 29
Starting from

$4350

pharmaceuticals

Visceral Leishmaniasis Treatment Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 November 29
Starting from

$4350

pharmaceuticals

Friedreich's Ataxia Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 November 29
Starting from

$4350

pharmaceuticals

Pars Planitis Treatment Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 November 29
Starting from

$4350